USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
JK AUTOIMMUNITY, INC.
Address:
755 Research ParkWay
OKLAHOMA CITY, OK 73104
Phone:
N/A
URL:
N/A
EIN:
731565223
DUNS:
42049440
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $385,000.00 3

Award List:

Diagnostic Assays for Rheumatic Diseases

Award Year / Program / Phase:
2001 / STTR / Phase I
Award Amount:
$99,999.00
Agency:
HHS
Principal Investigator:
Research Institution:
OKLAHOMA MEDICAL RESEARCH FOUNDATION
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): The diagnosis of systemic lupus erythematosus is a serious public health problem. Almost 90 percent of the 2,000,000 people who have been told that they have lupus do not fulfill the diagnostic criteria… More

Parallel Assays for Anti-Ro Peptide Diagnostics

Award Year / Program / Phase:
2003 / STTR / Phase I
Award Amount:
$175,000.00
Agency:
HHS
Principal Investigator:
Research Institution:
OKLAHOMA MEDICAL RESEARCH FOUNDATION
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by the applicant): Diagnosis of rheumatic diseases is inefficient, time consuming, and frustrating. Indeed, many patients suffer unnecessarily. We wish to develop a parallel assay system for the serology of autoimmune rheumatic diseases involving multiple analytes (on the… More

Comprehensive Genotyping for Susceptibility to Metabolic Muscle Disease

Award Year / Program / Phase:
2008 / STTR / Phase I
Award Amount:
$110,001.00
Agency:
HHS
Principal Investigator:
Research Institution:
N/A
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): The goal of this project is to develop a large-scale genotyping tool for metabolic muscle disease that can be applied to certain high risk groups in order to prevent life-threatening symptoms that are fast becoming a public health problem. The triggering of… More